nice II

patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Reply New Message

Prev Message Back To Forum Threaded View Next Message

emit

Rank: Vice President [?]

Points: 41186 [?]

Votes: 199 Score: 3.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

nice II

posted on Mar 09, 2016 10:19PM

ash111	Wednesday, 03/09/16 02:12:50 PM
Re: None
Post # of 3963

http://www.reuters.com/article/us-israel-radiation-treatment-idUSKCN0WB1ZJ?feedType=RSS&feedName=healthNews

Pluristem and kitov are the most potential stocks trading on TASE imo

http://www.tase.co.il/eng/general/company/pages/companymaindata.aspx?ShareID=01121730&CompanyID=001569&subDataType=0

Market Cap (NIS thousands)
472,245 is about $120m (I USD = 3.9 NIS)

1 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply